病毒学
逆转录酶
抗药性
生物
病毒
逆转录酶抑制剂
传输(电信)
蛋白酶抑制剂(药理学)
突变
慢病毒
蛋白酶
人类免疫缺陷病毒(HIV)
聚合酶链反应
病毒性疾病
西达
遗传学
病毒载量
酶
抗逆转录病毒疗法
基因
生物化学
电气工程
工程类
作者
Sara Nunes Vaz,Marta Giovanetti,Filipe Ferreira de Almeida Rego,Túlio de Oliveira,Siva Danaviah,Maria Luiza Freire Gonçalves,Luíz Carlos Júnior Alcântara,Carlos Brites
标识
DOI:10.1089/aid.2015.0166
摘要
Approximately 35 million people worldwide are infected with human immunodeficiency virus (HIV) around 3.2 million of whom are children under 15 years. Mother-to-child-transmission (MTCT) of HIV-1 accounts for 90% of all infections in children. Despite great advances in the prevention of MTCT in Brazil, children are still becoming infected. Samples from 19 HIV-1-infected families were collected. DNA was extracted and fragments from gag, pol, and env were amplified and sequenced directly. Phylogenetic reconstruction was performed. Drug resistance analyses were performed in pol and env sequences. We found 82.1% of subtype B and 17.9% of BF recombinants. A prevalence of 43.9% drug resistance-associated mutations in pol sequences was identified. Of the drug-naive children 33.3% presented at least one mutation related to protease inhibitor/nucleoside reverse transcriptase inhibitor/nonnucleoside reverse transcriptase inhibitor (PI/NRTI/NNRTI) resistance. The prevalence of transmitted drug resistance mutations was 4.9%. On env we found a low prevalence of HR1 (4.9%) and HR2 (14.6%) mutations.
科研通智能强力驱动
Strongly Powered by AbleSci AI